查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1869755

神经介入器材市场规模、份额和趋势分析报告：按产品、适应症、最终用途、地区和细分市场预测（2025-2033 年）

Neurointerventional Devices Market Size, Share & Trends Analysis Report By Product (Diagnostic Devices, Therapeutic Devices), By Indication (Acute Ischemic Stroke (AIS), Intracranial Aneurysm), By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 300 Pages | 商品交期: 2-10个工作天内

价格

神经介入器材市场摘要

2024年全球神经介入设备市场规模估计为29.5亿美元，预计2033年将达到49.6亿美元。

预计从 2025 年到 2033 年，该市场将以 5.9% 的复合年增长率成长。推动该市场成长要素是中风、脑动脉瘤、血管畸形和其他神经血管疾病的盛行率不断上升，以及老年人口的快速成长，而老年人更容易患上这些疾病。

与开放性手术相比，微创手术恢復更快、併发症更少，其日益增长的需求进一步推动了市场成长。中风、动脉瘤和其他神经血管疾病等神经系统疾病发生率的上升是神经介入器材市场的主要驱动力，因为这增加了对有效微创治疗的需求，这些治疗有望减少残疾、提高生存率并老龄化患者预后。世界神经病学联合会（WFN）指出，神经系统疾病的盛行率在不同年龄层之间存在差异，包括早产儿、新生儿、儿童、青少年、成人和老年人，老年人通常面临与年龄相关的多种疾病和体弱问题。 2024年全球疾病负担研究估计，届时全球43%的人口将受到神经系统疾病的影响，凸显了全球对神经介入器材和治疗方法的巨大需求。

技术进步，例如新一代血栓摘取支架、血流导向装置和先进的影像解决方案，正在改善治疗效果。新兴市场加快监管核准、改善报销政策以及扩大医疗基础设施，正在推动介入神经放射学器材的广泛应用。例如，2024年4月，《神经病学》杂誌发表的预测显示，到2050年，全球脑部疾病病例将达到49亿例，比2021年增加22%。预计全球各年龄层脑部疾病的失能调整后存活年（DALY）率也将显着上升10%，从2021年的每10万人5139 DALY上升到2050年的每10万人5666 DALY。头痛、阿兹海默症、忧郁症和焦虑症以及中风已被认为是导致脑部疾病盛行率和疾病负担预计激增的主要因素。

中风（尤其是缺血性中风）发病率的上升，推动了神经介入器材市场的发展，因为人们对高效、微创的取栓手术的需求日益增长。例如，根据美国疾病管制与预防中心（CDC）2024年的数据（见下表），美国每年将有超过79.5万人发生中风，显示对先进的介入神经放射学治疗方法的需求不断增加。世界卫生组织（WHO）估计，全球每年约有1500万人发生中风，其中约87%为缺血性中风。

根据世界中风组织 (WSO) 2022 年的报告，下表显示了缺血性中风的发生率和盛行率。

根据《实验性中风与转化医学杂誌》的报告，出血性中风约占所有病例的 10-15%，当血管破裂时，会导致血液流入脑组织（脑出血）或脑周围空间（蛛网膜下腔出血）。

动静脉畸形（AVM）是推动神经介入器材市场成长的关键因素，因为这些复杂的血管畸形需要精准且微创的治疗方法。先进影像技术的进步提高了AVM的检出率，并且人们越来越倾向于选择血管内治疗而非开放性手术，这些因素共同推动了对栓塞系统、导管和弹簧圈等专用神经介入器械的需求。医疗专业人员日益认识到早期疗育对于预防出血併发症的重要性，这进一步加速了先进介入神经放射学解决方案在AVM治疗中的应用。根据美国美国生物技术资讯中心（NCBI）发表的一项研究，约15%的动静脉畸形（AVM）在出现临床症状之前通常无症状。 41%至79%的AVM患者会出现颅内出血。蜘蛛网膜下腔出血是继脑动脉瘤之后导致颅内出血的第二大原因，约占所有蜘蛛网膜下腔出血的 10%。

人口老化正在推动神经血管治疗器械市场的发展。老年人更容易患有神经血管疾病，例如中风、动脉瘤和与老龄化相关的脑血管疾病。这种人口结构变化正在推动对微创治疗方法和先进神经血管器械的需求。例如，根据脑动脉瘤基金会2024年6月发布的数据，美国估计有680万人（约占总人口的1/50）患有未破裂的脑动脉瘤，年破裂率为每10万人8至10例。每年约有3万美国人发生脑动脉瘤破裂，平均每18分钟就有一例。全球每年约有50万人死于脑动脉瘤，其中一半患者年龄在50岁以下。大多数动脉瘤发生在40岁以后，发生率最高的年龄层为35至60岁。儿童也可能患上动脉瘤。脑动脉瘤在女性的发生率高于男性（男女比例约3:2），55岁以上女性的动脉瘤破裂风险约为男性的1.5倍。

目录

第一章调查方法和范围

第二章执行摘要

第三章 神经介入器材市场变数、趋势与范围

  • 市场体系展望
    • 附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 神经介入设备市场分析工具
    • 产业分析—波特五力分析
    • PESTEL 分析

第四章 神经介入器材市场：产品估算与趋势分析

  • 细分仪表板
  • 神经介入器材市场：产品差异分析及市场占有率（2024 年及 2030 年）
  • 诊断设备
  • 治疗设备

第五章 神经介入器材市场：适应症与趋势分析

  • 细分仪表板
  • 神经介入器材市场：自适应变化分析及市场占有率（2024 年及 2030 年）
  • 急性缺血性脑中风（AIS）
  • 颅内动脉瘤
  • 脑动脉狭窄
  • 动静脉畸形（AVM）
  • 椎血管畸形

第六章 神经介入器材市场：终端用户估算与趋势分析

  • 细分仪表板
  • 神经介入器材市场：最终用途差异分析及市场占有率（2024 年及 2030 年）
  • 医院
  • 专科诊所
  • 门诊手术中心
  • 其他的

第七章 神经介入器材市场：区域估算与趋势分析

  • 区域展望
  • 神经介入器材市场：区域差异分析及市场占有率（2024 年及 2030 年）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争情势

  • 市场参与企业分类
  • 主要企业简介
    • Terumo Neuro
    • NeuroSafe Medical Co., Ltd
    • ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
    • Brain Navi Biotechnology Co., Ltd.
    • Medtronic
    • Stryker
    • CERENOVUS（Johnson &Johnson）
    • Integra LifeSciences Corporation
    • Penumbra Inc
    • Balt SAS
    • B. Braun SE
    • Phenox GmbH
    • Shanghai MicroPort Medical（Group）Co. Ltd.
    • Boston Scientific Corporation
    • Meril
    • Gem srl
    • Sirtex（BlackSwan Vascular, Inc.）
    • INVAMED
    • Merit Medical Systems
    • Abbott
    • Acandis GmbH
    • Cook Medical
    • Imperative Care, Inc.
    • Rapid Medical
    • Koninklijke Philips NV
    • KANEKA CORPORATION
  • 热力图分析/企业市场分析
  • 公司市占率分析，2024 年
Product Code: GVR-4-68040-776-9

Neurointerventional Devices Market Summary

The global neurointerventional devices market size was estimated at USD 2.95 billion in 2024 and is projected to reach USD 4.96 billion by 2033, growing at a CAGR of 5.9% from 2025 to 2033. The market is primarily driven by the rising prevalence of stroke, brain aneurysms, vascular malformations and other neurovascular disorders, coupled with the rapidly growing aging population prone to such conditions.

Increasing demand for minimally invasive procedures, which offer faster recovery and fewer complications than open surgery, further accelerates market growth. The rising incidence of neurological disorders such as stroke, aneurysms, and other neurovascular conditions is a key driver of the neurointerventional devices market, as it increases the demand for effective, minimally invasive treatments that can reduce disability, improve survival rates, and enhance patient outcomes. According to the World Federation of Neurology (WFN), neurological disease prevalence varies across age groups, including preterm, neonatal, childhood, adolescent, adult, and older adults who often experience age-related multimorbidity and frailty. The 2024 Global Burden of Disease study estimated that 43% of the world's population is affected by a neurological disorder, underscoring the significant global demand for neurointerventional devices and treatments.

Technological advancements, including next-generation stent retrievers, flow diverters, and advanced imaging solutions, enhance treatment outcomes. Favorable regulatory approvals, improved reimbursement policies, and expanding healthcare infrastructure in emerging markets are supporting wider adoption of neurointerventional devices. For instance, in April 2024, Neurology journals have highlighted projections estimating that the number of brain disorder cases could reach 4.9 billion globally by 2050, marking a 22% increase compared to 2021. The all-age Disability-Adjusted Life Years (DALYs) rate of brain disorders is also expected to rise significantly by 10% globally, from 5,139 DALYs per 100,000 in 2021 to 5,666 DALYs per 100,000 in 2050. Headaches, Alzheimer's disease, depressive and anxiety disorders, and strokes are identified as the primary contributors to this anticipated surge in prevalence and disease burden.

The rising incidence of stroke, particularly ischemic stroke is propelling the neurointerventional devices market by increasing the demand for efficient and minimally invasive clot removal procedures. For instance, in 2024, CDC data highlighted, as presented in the table below, that over 795,000 people in the U.S. suffer a stroke each year, emphasizing the growing need for advanced neurointerventional treatment options.[ According to the WHO, the global incidence of stroke is estimated to be approximately 15 million people annually, with ischemic stroke representing about 87% of all stroke cases.

According to the World Stroke Organization 2022, the table below shows the incidence and prevalence of ischemic stroke.

According to the Journal of Experimental Stroke & Translational Medicine, Hemorrhagic stroke accounts for approximately 10-15% of cases and results from the rupture of a blood vessel, causing bleeding within the brain tissue (intracerebral hemorrhage) or into the space surrounding the brain (subarachnoid hemorrhage).

Arteriovenous malformations (AVMs) are a significant factor driving the growth of the neurointerventional devices market, as these complex vascular abnormalities require precise and minimally invasive treatment approaches. The increasing detection of AVMs through advanced imaging techniques and the growing preference for endovascular procedures over open surgery fuel the demand for specialized neurointerventional devices such as embolization systems, catheters, and coils. Rising awareness among healthcare professionals about early intervention to prevent hemorrhagic complications further accelerates the adoption of advanced neurointerventional solutions for AVM management. According to a research article published by the National Center for Biotechnology Information, arteriovenous malformations (AVMs) are often asymptomatic in about 15% of cases until a clinical event occurs. Between 41% and 79% of AVMs are present with intracranial hemorrhage. They are the second most common cause of intracranial bleeding after cerebral aneurysms, accounting for approximately 10% of all subarachnoid hemorrhages.

The growing aging population drives the neurointerventional devices market, as older adults are more prone to neurovascular conditions such as stroke, aneurysms, and age-related cerebrovascular diseases. This demographic trend increases the demand for minimally invasive interventions and advanced neurovascular devices. For instance, in June 2024, the Brain Aneurysm Foundation reported that an estimated 6.8 million people in the United States, about 1 in 50, have an unruptured brain aneurysm, with an annual rupture rate of 8-10 per 100,000 people. Each year, roughly 30,000 Americans experience a brain aneurysm rupture, which occurs on average every 18 minutes. Globally, brain aneurysms cause nearly 500,000 deaths annually, with half of the victims under 50. While most aneurysms develop after age 40 and are most common between ages 35 to 60, they can also occur in children. Women are more likely than men to have a brain aneurysm (3:2 ratio), and women over 55 faces approximately 1.5 times higher risk of rupture than men.

Global Neurointerventional Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global neurointerventional devices market report based on product, indication, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Diagnostic Devices
    • Catheters
    • Distal Access Catheters
    • Microcatheters
    • Others
    • Guidewires
    • Imaging Systems
  • Therapeutic Devices
    • Embolic Materials
    • Embolic Coils
    • Embolic Agents
    • Neurovascular Stents
    • Self-Expanding Stents
    • Balloon-Expandable Stents
    • Flow Diverter Stents
    • Coil-Assist Stents
    • Neurothrombectomy Devices
    • Intrasaccular Devices
    • Embolic Protection Devices
    • Others
  • Indication Outlook (Revenue, USD Million, 2021 - 2033)
  • Acute Ischemic Stroke (AIS)
  • Intracranial Aneurysm
  • Cerebral Arterial Stenosis
  • Arteriovenous Malformation (AVM)
  • Spinal Vascular Malformations
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgery Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Kuwait
    • UAE

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. Product
    • 1.2.3. Indication
    • 1.2.4. End Use
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Neurointerventional Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising Incidence of Neurovascular Disorders
      • 3.2.1.2. Growing Preference for Minimally Invasive Procedures
      • 3.2.1.3. Regulatory Approvals and Reimbursement Policies
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High procedural and device costs
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Rising prevalence of stroke and cerebrovascular disorders
      • 3.2.3.2. Integration of AI and robotics
    • 3.2.4. Market Challenges Analysis
      • 3.2.4.1. Complexity of neurovascular anatomy
      • 3.2.4.2. Device-related risks and failures
  • 3.3. Neurointerventional Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. Neurointerventional Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Neurointerventional Devices Market: Product Movement Analysis & Market Share, 2024 & 2030
  • 4.3. Diagnostic Devices
    • 4.3.1. Diagnostic Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.1. Catheters
        • 4.3.1.1.1. Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
          • 4.3.1.1.1.1. Distal Access Catheters
            • 4.3.1.1.1.1.1. Distal Access Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
          • 4.3.1.1.1.2. Microcatheters
            • 4.3.1.1.1.1.2. Microcatheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
          • 4.3.1.1.1.3. Others
            • 4.3.1.1.1.1.3. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.2. Guidewires
        • 4.3.1.1.2. Guidewires Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.3. Imaging Systems
        • 4.3.1.3.1. Imaging Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Therapeutic Devices
    • 4.4.1. Therapeutic Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.1.1. Embolic Materials
        • 4.4.1.1.1. Embolic Materials Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
          • 4.4.1.1.1.1. Embolic Coils
            • 4.4.1.1.1.1.1. Embolic Coils Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
          • 4.4.1.1.1.2. Embolic Agents
            • 4.2.1.1.1.2.1. Embolic Agents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.1.2. Neurovascular Stents
        • 4.4.1.2.1. Neurovascular Stents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
          • 4.4.1.2.1.1. Self-Expanding Stents
            • 4.4.1.2.1.1.1. Self-Expanding Stents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
          • 4.4.1.2.1.2. Balloon-Expandable Stents
            • 4.4.1.2.1.2.1. Balloon-Expandable Stents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
          • 4.4.1.2.1.3. Flow Diverter Stents
            • 4.4.1.2.1.3.1. Flow Diverter Stents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
          • 4.4.1.2.1.4. Coil-Assist Stents
            • 4.4.1.2.1.4.1. Coil-Assist Stents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.1.3. Neurothrombectomy Devices
        • 4.4.1.3.1. Neurothrombectomy Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.1.4. Intrasaccular Devices
        • 4.4.1.4.1. Intrasaccular Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.1.5. Embolic Protection Devices
        • 4.4.1.5.1. Embolic Protection Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.1.6. Others
        • 4.4.1.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Neurointerventional Devices Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Neurointerventional Devices Market: Indication Movement Analysis & Market Share, 2024 & 2030
  • 5.3. Acute Ischemic Stroke (AIS)
    • 5.3.1. Acute Ischemic Stroke (AIS) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Intracranial Aneurysm
    • 5.4.1. Intracranial Aneurysm Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Cerebral Arterial Stenosis
    • 5.5.1. Cerebral Arterial Stenosis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Arteriovenous Malformation (AVM)
    • 5.6.1. Arteriovenous Malformation (AVM) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Spinal Vascular Malformations
    • 5.7.1. Spinal Vascular Malformations Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Neurointerventional Devices Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Neurointerventional Devices Market: End Use Movement Analysis & Market Share, 2024 & 2030
  • 6.3. Hospitals
    • 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Specialty Clinics
    • 6.4.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Ambulatory Surgery Centers
    • 6.5.1. Ambulatory Surgery Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Neurointerventional Devices Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Neurointerventional Devices Market: Regional Movement Analysis & Market Share, 2024 & 2030
  • 7.3. North America
    • 7.3.1. North America Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Scenario
      • 7.3.2.4. Reimbursement Scenario
      • 7.3.2.5. U.S. Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Scenario
      • 7.3.3.4. Reimbursement Scenario
      • 7.3.3.5. Canada Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Scenario
      • 7.3.4.4. Reimbursement Scenario
      • 7.3.4.5. Mexico Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Scenario
      • 7.4.2.4. Reimbursement Scenario
      • 7.4.2.5. UK Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Scenario
      • 7.4.3.4. Reimbursement Scenario
      • 7.4.3.5. Germany Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Scenario
      • 7.4.4.4. Reimbursement Scenario
      • 7.4.4.5. France Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Scenario
      • 7.4.5.4. Reimbursement Scenario
      • 7.4.5.5. Italy Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Scenario
      • 7.4.6.4. Reimbursement Scenario
      • 7.4.6.5. Spain Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Scenario
      • 7.4.7.4. Reimbursement Scenario
      • 7.4.7.5. Denmark Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Scenario
      • 7.4.8.4. Reimbursement Scenario
      • 7.4.8.5. Sweden Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Scenario
      • 7.4.9.4. Reimbursement Scenario
      • 7.4.9.5. Norway Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Scenario
      • 7.5.2.4. Reimbursement Scenario
      • 7.5.2.5. Japan Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Scenario
      • 7.5.3.4. Reimbursement Scenario
      • 7.5.3.5. China Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Scenario
      • 7.5.4.4. Reimbursement Scenario
      • 7.5.4.5. India Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Scenario
      • 7.5.5.4. Reimbursement Scenario
      • 7.5.5.5. South Korea Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Scenario
      • 7.5.6.4. Reimbursement Scenario
      • 7.5.6.5. Australia Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Scenario
      • 7.5.7.4. Reimbursement Scenario
      • 7.5.7.5. Thailand Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Scenario
      • 7.6.2.4. Reimbursement Scenario
      • 7.6.2.5. Brazil Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Scenario
      • 7.6.3.4. Reimbursement Scenario
      • 7.6.3.5. Argentina Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Middle East & Africa
    • 7.7.1. Middle East & Africa Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Scenario
      • 7.7.2.4. Reimbursement Scenario
      • 7.7.2.5. South Africa Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Scenario
      • 7.7.3.4. Reimbursement Scenario
      • 7.7.3.5. Saudi Arabia Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Scenario
      • 7.7.4.4. Reimbursement Scenario
      • 7.7.4.5. UAE Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Scenario
      • 7.7.5.4. Reimbursement Scenario
      • 7.7.5.5. Kuwait Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Terumo Neuro
      • 8.2.1.1. Company Overview
      • 8.2.1.2. Financial Performance
      • 8.2.1.3. Technology Benchmarking
      • 8.2.1.4. Strategic Initiatives
    • 8.2.2. NeuroSafe Medical Co., Ltd
      • 8.2.2.1. Company Overview
      • 8.2.2.2. Financial Performance
      • 8.2.2.3. Technology Benchmarking
      • 8.2.2.4. Strategic Initiatives
    • 8.2.3. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
      • 8.2.3.1. Company Overview
      • 8.2.3.2. Financial Performance
      • 8.2.3.3. Technology Benchmarking
      • 8.2.3.4. Strategic Initiatives
    • 8.2.4. Brain Navi Biotechnology Co., Ltd.
      • 8.2.4.1. Company Overview
      • 8.2.4.2. Financial Performance
      • 8.2.4.3. Technology Benchmarking
      • 8.2.4.4. Strategic Initiatives
    • 8.2.5. Medtronic
      • 8.2.5.1. Company Overview
      • 8.2.5.2. Financial Performance
      • 8.2.5.3. Technology Benchmarking
      • 8.2.5.4. Strategic Initiatives
    • 8.2.6. Stryker
      • 8.2.6.1. Company Overview
      • 8.2.6.2. Financial Performance
      • 8.2.6.3. Technology Benchmarking
      • 8.2.6.4. Strategic Initiatives
    • 8.2.7. CERENOVUS (Johnson & Johnson)
      • 8.2.7.1. Company Overview
      • 8.2.7.2. Financial Performance
      • 8.2.7.3. Technology Benchmarking
      • 8.2.7.4. Strategic Initiatives
    • 8.2.8. Integra LifeSciences Corporation
      • 8.2.8.1. Company Overview
      • 8.2.8.2. Financial Performance
      • 8.2.8.3. Technology Benchmarking
      • 8.2.8.4. Strategic Initiatives
    • 8.2.9. Penumbra Inc
      • 8.2.9.1. Company Overview
      • 8.2.9.2. Financial Performance
      • 8.2.9.3. Technology Benchmarking
      • 8.2.9.4. Strategic Initiatives
    • 8.2.10. Balt SAS
      • 8.2.10.1. Company Overview
      • 8.2.10.2. Financial Performance
      • 8.2.10.3. Technology Benchmarking
      • 8.2.10.4. Strategic Initiatives
    • 8.2.11. B. Braun SE
      • 8.2.11.1. Company Overview
      • 8.2.11.2. Financial Performance
      • 8.2.11.3. Technology Benchmarking
      • 8.2.11.4. Strategic Initiatives
    • 8.2.12. Phenox GmbH
      • 8.2.12.1. Company Overview
      • 8.2.12.2. Financial Performance
      • 8.2.12.3. Technology Benchmarking
      • 8.2.12.4. Strategic Initiatives
    • 8.2.13. Shanghai MicroPort Medical (Group) Co. Ltd.
      • 8.2.13.1. Company Overview
      • 8.2.13.2. Financial Performance
      • 8.2.13.3. Technology Benchmarking
      • 8.2.13.4. Strategic Initiatives
    • 8.2.14. Boston Scientific Corporation
      • 8.2.14.1. Company Overview
      • 8.2.14.2. Financial Performance
      • 8.2.14.3. Technology Benchmarking
      • 8.2.14.4. Strategic Initiatives
    • 8.2.15. Meril
      • 8.2.15.1. Company Overview
      • 8.2.15.2. Financial Performance
      • 8.2.15.3. Technology Benchmarking
      • 8.2.15.4. Strategic Initiatives
    • 8.2.16. Gem srl
      • 8.2.16.1. Company Overview
      • 8.2.16.2. Financial Performance
      • 8.2.16.3. Technology Benchmarking
      • 8.2.16.4. Strategic Initiatives
    • 8.2.17. Sirtex (BlackSwan Vascular, Inc.)
      • 8.2.17.1. Company Overview
      • 8.2.17.2. Financial Performance
      • 8.2.17.3. Technology Benchmarking
      • 8.2.17.4. Strategic Initiatives
    • 8.2.18. INVAMED
      • 8.2.18.1. Company Overview
      • 8.2.18.2. Financial Performance
      • 8.2.18.3. Technology Benchmarking
      • 8.2.18.4. Strategic Initiatives
    • 8.2.19. Merit Medical Systems
      • 8.2.19.1. Company Overview
      • 8.2.19.2. Financial Performance
      • 8.2.19.3. Technology Benchmarking
      • 8.2.19.4. Strategic Initiatives
    • 8.2.20. Abbott
      • 8.2.20.1. Company Overview
      • 8.2.20.2. Financial Performance
      • 8.2.20.3. Technology Benchmarking
      • 8.2.20.4. Strategic Initiatives
    • 8.2.21. Acandis GmbH
      • 8.2.21.1. Company Overview
      • 8.2.21.2. Financial Performance
      • 8.2.21.3. Technology Benchmarking
      • 8.2.21.4. Strategic Initiatives
    • 8.2.22. Cook Medical
      • 8.2.22.1. Company Overview
      • 8.2.22.2. Financial Performance
      • 8.2.22.3. Technology Benchmarking
      • 8.2.22.4. Strategic Initiatives
    • 8.2.23. Imperative Care, Inc.
      • 8.2.23.1. Company Overview
      • 8.2.23.2. Financial Performance
      • 8.2.23.3. Technology Benchmarking
      • 8.2.23.4. Strategic Initiatives
    • 8.2.24. Rapid Medical
      • 8.2.24.1. Company Overview
      • 8.2.24.2. Financial Performance
      • 8.2.24.3. Technology Benchmarking
      • 8.2.24.4. Strategic Initiatives
    • 8.2.25. Koninklijke Philips N.V.
      • 8.2.25.1. Company Overview
      • 8.2.25.2. Financial Performance
      • 8.2.25.3. Technology Benchmarking
      • 8.2.25.4. Strategic Initiatives
    • 8.2.26. KANEKA CORPORATION
      • 8.2.26.1. Company Overview
      • 8.2.26.2. Financial Performance
      • 8.2.26.3. Technology Benchmarking
      • 8.2.26.4. Strategic Initiatives
  • 8.3. Heat Map Analysis/ Company Market Position Analysis
  • 8.4. Company Market Share Analysis, 2024

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America Neurointerventional devices market, by country, 2021 - 2033 (USD Million)
  • Table 4 North America Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 5 North America Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 6 North America Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 7 U.S. Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 8 U.S. Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 9 U.S. North America Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 10 Canada Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 11 Canada Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 12 Canada North America Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 13 Mexico Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 14 Mexico Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 15 Mexico North America Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Europe Neurointerventional devices market, by country, 2021 - 2033 (USD Million)
  • Table 17 Europe Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 18 Europe Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 19 Europe North America Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 20 UK Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 21 UK Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 22 UK Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 23 Germany Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 24 Germany Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 25 Germany Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 26 France Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 27 France Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 28 France Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 29 Italy Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 30 Italy Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 31 Italy Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 32 Spain Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 33 Spain Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 34 Spain Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 35 Norway Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 36 Norway Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 37 Norway Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 38 Sweden Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 39 Sweden Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 40 Sweden Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Denmark Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 42 Denmark Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 43 Denmark Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 44 Asia Pacific Neurointerventional devices market, by country, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 48 China Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 49 China Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 50 China Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 51 Japan Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 52 Japan Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 53 Japan Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 54 India Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 55 India Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 56 India Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 57 Australia Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 58 Australia Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 59 Australia Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 60 South Korea Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 61 South Korea Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 62 South Korea Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 63 Thailand Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 64 Thailand Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 65 Thailand Korea Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 66 Latin America Neurointerventional devices market, by country, 2021 - 2033 (USD Million)
  • Table 67 Latin America Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 68 Latin America Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 69 Latin America Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 70 Brazil Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 71 Brazil Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 72 Brazil Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 73 Argentina Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 74 Argentina Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 75 Argentina Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 76 Middle East & Africa Neurointerventional devices market, by country, 2021 - 2033 (USD Million)
  • Table 77 Middle East & Africa Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 78 Middle East & Africa Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 79 Middle East & Africa Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 80 South Africa Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 81 South Africa Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 82 South Africa Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 83 Saudi Arabia Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 84 Saudi Arabia Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 85 Saudi Arabia Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 86 UAE Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 87 UAE Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 88 UAE Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 89 Kuwait Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 90 Kuwait Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 91 Kuwait Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Neurointerventional devices market segmentation
  • Fig. 3 Market research process
  • Fig. 4 Information procurement process
  • Fig. 5 Primary research pattern
  • Fig. 6 Neurointerventional devices market snapshot, 2024 (USD Million)
  • Fig. 7 Segment snapshot, USD Million
  • Fig. 8 Competitive landscape snapshot
  • Fig. 9 Penetration & growth prospect mapping, by Technology
  • Fig. 10 Market driver analysis (Current & future impact)
  • Fig. 11 Market restraint analysis (Current & future impact)
  • Fig. 12 Market opportunity analysis (Current & future impact)
  • Fig. 13 Primary market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Diagnostic devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Catheters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Guidewires market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Imaging systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Therapeutic devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Embolic materials market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Neurovascular stents market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Neurothrombectomy devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Intrasaccular devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Embolic protection devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Acute ischemic stroke (AIS) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Intracranial aneurysm market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Cerebral arterial stenosis market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Arteriovenous malformation (AVM) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Spinal vascular malformations market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Specialty clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Ambulatory surgery centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Neurointerventional devices market: Regional key takeaways (USD Million)
  • Fig. 35 Neurointerventional devices market: Regional outlook, 2021 & 2030, USD Million
  • Fig. 36 North America Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 U.S. Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Canada Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Mexico Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Europe Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 UK Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Germany Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 France Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Spain Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Italy Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Sweden Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Norway Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Denmark Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Asia Pacific Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 China Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Japan Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 India Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 South Korea Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Australia Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Thailand Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Latin America Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Brazil Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Argentina Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Middle East and Africa Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 South Africa Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Saudi Arabia Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 UAE Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Kuwait Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 List of key emerging companies
  • Fig. 65 Company market share analysis, 2024
  • Fig. 66 Market differentiators
  • Fig. 67 Competitive dashboard analysis
  • Fig. 68 Regional network map